Verrica Pharmaceuticals Inc. (VRCA) income statement
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$2.85−0.29 (-9.08%)
Close on Nov 18, 2026Market cap $49.05MP/E –Yield –
Verrica Pharmaceuticals Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -93.6%
- Net margin
- -102.8%
- Return on equity, FY2025
- -240.4%
Financial strength
- Current ratio
- 1.45
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 49.9%
Valuation
- P/E ratio
- –
- Price to sales
- 1.62
- Price to book
- 11.39
- Dividend yield
- –
See a number that looks wrong?